Wollongong Clinical Research - PPDS
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grimsdale, Joanne
NCT06291857: A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Not yet recruiting
3
7950
RoW
CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, COVID-19 and influenza combination, Novavax COVID-19 Vaccine, Novavax SARS-CoV-2 rS vaccine, tNIV Vaccine, Trivalent Nanoparticle Influenza Hemagglutinin Vaccine, Fluzone High Dose, Fluzone HD
Novavax
COVID-19
03/25
04/25
ACTRN12620001234909: To assess the effects of two cosmetic skin creams containing stem cell-derived growth factors developed by CK Cell Technologies Pty Ltd.

Not yet recruiting
N/A
23
 
CK Cell Technologies Pty Ltd, CK Cell Technologies Pty Ltd
Facial skin
 
 

Download Options